Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Auteurs : Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K
Jaar : 2016
Journal : Oncoimmunology
Volume : 6
Pagina's : e1257452

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Auteurs : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Jaar : 2016
Journal : PLoS One
Volume : 11(7)
Pagina's : e0154009

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.

Auteurs : Liberale G, El Houkayem M, Viste C, Bouazza F, Moreau M, El Nakadi I, Veys I
Jaar : 2016
Journal : Support Care Cancer
Volume : 24(12)
Pagina's : 5035-40

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.

Auteurs : Dhondt V, Goffin F, Roca L, Dresse D, Leroy C, Kerger J, Cordier L, de Forges H, Veys I, Liberale G
Jaar : 2016
Journal : Int J Gynecol Cancer
Volume : 26(5)
Pagina's : 912-7

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Auteurs : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pagina's : 217-24

Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.

Auteurs : Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, Dechene J, Ferster A, Veys I, Fastrez M, Englert Y, Demeestere I
Jaar : 2014
Journal : Hum. Reprod.
Volume : 29(9)
Pagina's : 1931-40

Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute.

Auteurs : Philippson C, Simon S, Vandekerkhove C, Hertens D, Veys I, Noterman D, De Neubourg F, Larsimont D, Bourgeois P, Van Houtte P, Nogaret JM
Jaar : 2014
Journal : Int J Breast Cancer
Volume : 2014
Pagina's : 627352

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature

Auteurs : Amzerin M, Garcia C, Stanciu C, Veys I, Awada A, Errihani H, Gombos A
Jaar : 2014
Journal : F1000Res
Volume : 3
Pagina's : 255

Genomic grade adds prognostic value in invasive lobular carcinoma.

Auteurs : Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Haussy S, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart-Gebhart M, Sotiriou C
Jaar : 2013
Journal : Ann Oncol
Volume : 24
Pagina's : 377-384

Genomic grade adds prognostic value in invasive lobular carcinoma.

Auteurs : Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Sandy H, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart-Gebhart M, Sotiriou C
Jaar : 2013
Journal : Ann Oncol
Volume : 24(2)
Pagina's : 377-84

CD4+ follicular helper T cell infiltration predicts breast cancer survival.

Auteurs : Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothé F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart-Gebhart M, Sotiriou C, Willard-Gallo K
Jaar : 2013
Journal : J Clin Invest
Volume : 123(7)
Pagina's : 2873-92

Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis.

Auteurs : Azim HA, Singhal S, Ignatiadis M, Desmedt C, Fumagalli D, Veys I, Larsimont D, Piccart-Gebhart M, Michiels S, Sotiriou C
Jaar : 2013
Journal : PLoS One
Volume : 8(4)
Pagina's : e62451

HER2-positive circulating tumor cells in breast cancer.

Auteurs : Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart-Gebhart M, Sotiriou C
Jaar : 2011
Journal : PLoS One
Volume : 6(1)
Pagina's : e15624

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’Institut Jules Bordet.

Auteurs : Philippson C, Simon S, Vandekerkhove C, Veys I, Noterman D, Hertens D, De Neubourg F, Larsimont D, Van Houtte P, Nogaret JM
Jaar : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pagina's : 560-72

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases.

Auteurs : Toussaint A, Nogaret JM, Veys I, Hertens D, Noterman D, De Neubourg F, Larsimont D, Bourgeois P
Jaar : 2011
Journal : Breast J
Volume : 17(4)
Pagina's : 337-42